These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 1945224)

  • 1. A peripherally implanted permanent central venous access device.
    Morris P; Buller R; Kendall S; Anderson B
    Obstet Gynecol; 1991 Dec; 78(6):1138-42. PubMed ID: 1945224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
    Koonings PP; Given FT
    J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
    Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH
    Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
    Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
    Subramaniam A; Kim KH; Bryant SA; Kimball KJ; Huh WK; Straughn JM; Estes JM; Alvarez RD
    Gynecol Oncol; 2011 Oct; 123(1):54-7. PubMed ID: 21742372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Totally implantable central venous access devices in adult oncological patients.
    Florio G; Del Papa M; Mari A; Carnì D
    Chir Ital; 2008; 60(5):697-702. PubMed ID: 19062492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies.
    Cohn DE; Mutch DG; Rader JS; Farrell M; Awantang R; Herzog TJ
    Gynecol Oncol; 2001 Dec; 83(3):533-6. PubMed ID: 11733967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.
    Gleeson NC; Fiorica JV; Mark JE; Pinelli DM; Hoffman MS; Roberts WS; Cavanagh D
    Gynecol Oncol; 1993 Dec; 51(3):372-6. PubMed ID: 8112648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Permanent venous access through a +portacath reservoir in patients receiving prolonged chemotherapy].
    García H; Díaz R; Pablo Barés J; Nevah E; Fábrega JM
    Rev Med Panama; 1994 Jan; 19(1):8-12. PubMed ID: 7938718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with the intravenous totally implanted port in patients with gynecologic malignancies.
    Nelson BE; Mayer AR; Tseng PC; Schwartz PE
    Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
    Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
    Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Venous access devices in oncology].
    Maňásek V; Soumarová R; Kociánová I; Maňásková M
    Klin Onkol; 2012; 25(1):9-16. PubMed ID: 22348215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term central venous access with a peripherally placed subcutaneous infusion port: initial results.
    Andrews JC; Walker-Andrews SC; Ensminger WD
    Radiology; 1990 Jul; 176(1):45-7. PubMed ID: 2353108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing concepts in long-term central venous access: catheter selection and cost savings.
    Horattas MC; Trupiano J; Hopkins S; Pasini D; Martino C; Murty A
    Am J Infect Control; 2001 Feb; 29(1):32-40. PubMed ID: 11172316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
    Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF
    Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion of Groshong central venous catheters utilizing fluoroscopic techniques.
    Burnett AF; Lossef SV; Barth KH; Grendys EC; Johnson JC; Barter JF; Barnes WA
    Gynecol Oncol; 1994 Jan; 52(1):69-73. PubMed ID: 8307504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Implantable catheter systems].
    Willnow U
    Praxis (Bern 1994); 1998 Sep; 87(36):1135-9. PubMed ID: 9782741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral ports are a new option for central venous access.
    Schuman E; Ragsdale J
    J Am Coll Surg; 1995 Apr; 180(4):456-60. PubMed ID: 7719550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.